var data={"title":"Recessive X-linked ichthyosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Recessive X-linked ichthyosis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/contributors\" class=\"contributor contributor_credentials\">Jennifer L Hand, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/contributors\" class=\"contributor contributor_credentials\">Moise L Levy, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/contributors\" class=\"contributor contributor_credentials\">Rosamaria Corona, MD, DSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 10, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H98140592\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Recessive X-linked ichthyosis (XLI, MIM #308100), also called steroid sulfatase deficiency, is an X-linked recessive, nonsyndromic ichthyosis caused by deletions or mutations in the <em>STS</em> gene encoding the steroid sulfatase enzyme [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/1\" class=\"abstract_t\">1</a>]. Due to location of the <em>STS</em> gene within a small region of the X-chromosome that escapes X-inactivation (lyonization), recessive XLI<em> </em>affects almost exclusively males.</p><p>The disease presents at birth or in early infancy with dry skin and a tendency to form scales on the extremities and trunk. Along with ichthyosis vulgaris, the phenotype of X-linked ichthyosis tends to be milder than most other hereditary forms of ichthyosis.</p><p>This topic will review the clinical features, diagnosis, and management of XLI. An overview of syndromic and nonsyndromic ichthyoses (<a href=\"image.htm?imageKey=DERM%2F90504\" class=\"graphic graphic_table graphicRef90504 \">table 1</a>) is presented separately. (See <a href=\"topic.htm?path=overview-and-classification-of-the-inherited-ichthyoses\" class=\"medical medical_review\">&quot;Overview and classification of the inherited ichthyoses&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H98140598\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Recessive XLI is the second most frequent ichthyosis after ichthyosis vulgaris. It is reported worldwide in all ethnic groups and affects almost exclusively males. XLI incidence ranges from 1 in 1300 to 1 in 9000 male births [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/2-5\" class=\"abstract_t\">2-5</a>].</p><p class=\"headingAnchor\" id=\"H98140604\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The majority of cases of recessive XLI are caused by complete deletion of the steroid sulfatase gene (<em>STS</em>) on chromosome Xp22.3 [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/6,7\" class=\"abstract_t\">6,7</a>]. Other cases result from partial deletion or point mutations of <em>STS </em>[<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/8,9\" class=\"abstract_t\">8,9</a>]<em>.</em> Deletions or mutations of the <em>STS</em> gene cause complete loss of steroid sulfatase enzyme activity. Affected males inherit the X-chromosome bearing a deleted or mutated gene from their asymptomatic carrier mothers, although rare sporadic cases have been reported [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/10,11\" class=\"abstract_t\">10,11</a>]. In 5 to 8 percent of cases, the deletion includes genes adjacent to <em>STS, </em>resulting in a number of contiguous gene syndromes [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/12,13\" class=\"abstract_t\">12,13</a>]. (See <a href=\"#H98140652\" class=\"local\">'Contiguous gene syndromes'</a> below.)</p><p>Steroid sulfatase (STS) is a 65 kDa microsomal enzyme that localizes to the endoplasmic reticulum, Golgi apparatus, and endosomal membranes, including coated pits of placenta and several other tissues. STS hydrolyzes alkyl steroid sulfates (eg, dehydroepiandrosterone sulfate [DHEAS], aryl steroid sulfates) to their unconjugated (unsulfated) forms [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/14,15\" class=\"abstract_t\">14,15</a>]. In the epidermis, the steroid sulfatase activity is high in the granular layer and persists in the stratum corneum, where it contributes to the production of cholesterol available to form the extracellular lamellar bilayers and participates in the regulation of permeability barrier function and desquamation. Deficient STS activity leads to accumulation of cholesterol sulfate in the stratum corneum, which causes increased corneocyte cohesion, retention hyperkeratosis, and impaired skin permeability [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/14,16-18\" class=\"abstract_t\">14,16-18</a>].</p><p>In women pregnant with an affected fetus, placental steroid sulfatase deficiency causes low maternal urinary and blood unconjugated estriol levels, due to inadequate deconjugation of DHEAS, which is necessary for estrogen synthesis [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/14\" class=\"abstract_t\">14</a>]. Normally, the STS enzyme synthesizes estriol in the placenta, which circulates in maternal blood. When a fetus is affected with XLI (steroid sulfatase deficiency), the mother, correspondingly, has abnormally low levels of unconjugated serum estriol (uE3) during pregnancy. If a mother carrying an XLI-affected fetus is offered and pursues a second-trimester screening test for Down syndrome (see <a href=\"topic.htm?path=laboratory-issues-related-to-maternal-serum-screening-for-down-syndrome\" class=\"medical medical_review\">&quot;Laboratory issues related to maternal serum screening for Down syndrome&quot;</a>), which relies on levels of serum analytes including uE3, the screen will be abnormal and not useful for detection of Down syndrome.</p><p class=\"headingAnchor\" id=\"H55326\"><span class=\"h1\">PATHOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The histologic features of recessive XLI may be nonspecific, with a wide range of changes in the stratum corneum and granular layer reported. For example, the stratum corneum may appear normal or have thick hyperkeratosis (<a href=\"image.htm?imageKey=DERM%2F104127\" class=\"graphic graphic_picture graphicRef104127 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/1\" class=\"abstract_t\">1</a>]. The granular layer may appear normal (<a href=\"image.htm?imageKey=DERM%2F104128\" class=\"graphic graphic_picture graphicRef104128 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/19\" class=\"abstract_t\">19</a>], diminished [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/14\" class=\"abstract_t\">14</a>], or absent (<a href=\"image.htm?imageKey=DERM%2F104129\" class=\"graphic graphic_picture graphicRef104129 \">picture 3</a>) [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/19\" class=\"abstract_t\">19</a>]. In contrast with early reports of a normal to slightly thickened granular layer in recessive XLI, a review of slides from eight patients found that the granular layer was generally normal or thinned [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/20\" class=\"abstract_t\">20</a>].</p><p class=\"headingAnchor\" id=\"H98140610\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to ichthyosis, steroid sulfatase deficiency may be associated with several extracutaneous manifestations, including corneal opacities, cryptorchidism, and, less commonly, neurologic, cognitive, and developmental abnormalities [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/1,21,22\" class=\"abstract_t\">1,21,22</a>].</p><p class=\"headingAnchor\" id=\"H98140622\"><span class=\"h2\">Cutaneous features</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The cutaneous features of recessive XLI may appear in the first few weeks of life with mild, diffuse scaling (<a href=\"image.htm?imageKey=DERM%2F103928%7EDERM%2F103927%7EDERM%2F103929%7EDERM%2F103930\" class=\"graphic graphic_picture graphicRef103928 graphicRef103927 graphicRef103929 graphicRef103930 \">picture 4A-D</a>) and develop gradually over the following months. A presentation with a collodion membrane at birth (&quot;collodion baby&quot;) is unusual in XLI and most parents do not describe noticeable skin scale or dryness at birth.</p><p>Over time, the mild desquamation may be replaced by larger polygonal translucent scales (<a href=\"image.htm?imageKey=PEDS%2F66723%7EDERM%2F90658\" class=\"graphic graphic_picture graphicRef66723 graphicRef90658 \">picture 5A-B</a>) [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/23\" class=\"abstract_t\">23</a>]. The scales may become platelike and adherent with a brownish color, and involve particularly the anterior aspect of the lower extremities. The flexural areas (including the popliteal (<a href=\"image.htm?imageKey=DERM%2F103931\" class=\"graphic graphic_picture graphicRef103931 \">picture 6</a>) and antecubital (<a href=\"image.htm?imageKey=DERM%2F103932\" class=\"graphic graphic_picture graphicRef103932 \">picture 7</a>) fossae, palms and soles, and the central face) are often spared, but may be involved. During childhood, the scalp, preauricular areas, and neck may be involved (&quot;dirty neck&quot; appearance) [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/24\" class=\"abstract_t\">24</a>].</p><p>The scales tend to increase throughout childhood and then stabilize during adolescence with little subsequent change. In some patients, a concurrent ichthyosis vulgaris <span class=\"nowrap\">and/or</span> atopic dermatitis may exacerbate the symptoms [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/25-27\" class=\"abstract_t\">25-27</a>]. (See <a href=\"#H98140688\" class=\"local\">'Differential diagnosis'</a> below.)</p><p>Pruritus is usually absent.&nbsp;The desquamation improves during the summer months and is worsened by dry and cold weather [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/24\" class=\"abstract_t\">24</a>].</p><p class=\"headingAnchor\" id=\"H59463924\"><span class=\"h2\">Extracutaneous features</span></p><p class=\"headingAnchor\" id=\"H98140628\"><span class=\"h3\">Ocular</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Harmless &quot;punctate corneal opacities&quot; are the most characteristic eye finding, present in up to 50 percent of affected males and 25 percent of carrier females [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/28\" class=\"abstract_t\">28</a>]. The appearance is described as fine, hazy or &quot;flour-like&quot; comma-shaped dots in the cornea, anterior to Descemet's membrane, best visualized using a slit lamp (<a href=\"image.htm?imageKey=DERM%2F103934\" class=\"graphic graphic_picture graphicRef103934 \">picture 8</a>) [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/25\" class=\"abstract_t\">25</a>]. In vivo confocal microscopy has also been reported to be useful for visualization [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/29\" class=\"abstract_t\">29</a>]. These punctate corneal opacities are usually asymptomatic and only rarely can cause recurrent corneal erosions [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/1,28\" class=\"abstract_t\">1,28</a>].</p><p class=\"headingAnchor\" id=\"H98140634\"><span class=\"h3\">Genitourinary</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cryptorchidism is described in up to 20 percent of affected boys [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/1\" class=\"abstract_t\">1</a>]. Despite cryptorchidism, affected males have normal sexual development, testosterone levels, and fertility [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/1\" class=\"abstract_t\">1</a>]. Of particular concern to patients and families is a possible association of recessive XLI with testicular germ cell cancer independent of cryptorchidism. However, the data to support this association are weak, with only a few cases reported in the literature [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/30,31\" class=\"abstract_t\">30,31</a>]. (See <a href=\"topic.htm?path=undescended-testes-cryptorchidism-in-children-management\" class=\"medical medical_review\">&quot;Undescended testes (cryptorchidism) in children: Management&quot;</a>.)</p><p>There are a few case reports of nephrotic syndrome associated with recessive XLI [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/32-35\" class=\"abstract_t\">32-35</a>]. However, a true association has not been proven.</p><p class=\"headingAnchor\" id=\"H98140646\"><span class=\"h3\">Cognitive and behavioral</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Boys with recessive XLI may have a higher rate of cognitive and behavioral disorders, compared with nonaffected individuals in the same age range. In a study of 25 boys with recessive XLI, 10 fulfilled the criteria for attention deficit hyperactivity disorder (ADHD), especially the inattentive subtype, and five of the criteria for an autistic-spectrum disorder or related <span class=\"nowrap\">language/communication</span> difficulty [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/21\" class=\"abstract_t\">21</a>]. (See <a href=\"topic.htm?path=attention-deficit-hyperactivity-disorder-in-children-and-adolescents-epidemiology-and-pathogenesis\" class=\"medical medical_review\">&quot;Attention deficit hyperactivity disorder in children and adolescents: Epidemiology and pathogenesis&quot;</a> and <a href=\"topic.htm?path=autism-spectrum-disorder-terminology-epidemiology-and-pathogenesis\" class=\"medical medical_review\">&quot;Autism spectrum disorder: Terminology, epidemiology, and pathogenesis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H98140652\"><span class=\"h2\">Contiguous gene syndromes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Abnormal recombination of homologous sequences in the <em>STS</em> chromosomal region may cause terminal or interstitial deletions that include adjacent genes, resulting in complicated clinical phenotypes [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/36\" class=\"abstract_t\">36</a>]. In addition to ichthyosis, abnormalities reported in male patients with recessive XLI and contiguous gene syndromes include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mental retardation [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/37,38\" class=\"abstract_t\">37,38</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypogonadotropic hypogonadism and anosmia (Kallmann syndrome, MIM #308700), caused by a large deletion of the short arm of the X-chromosome proximal to and including the&nbsp;<em>STS</em>&nbsp;gene&nbsp;[<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/39\" class=\"abstract_t\">39</a>] (see <a href=\"topic.htm?path=isolated-gonadotropin-releasing-hormone-deficiency-idiopathic-hypogonadotropic-hypogonadism\" class=\"medical medical_review\">&quot;Isolated gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chondrodysplasia punctata, nasal hypoplasia, and mental retardation [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/40-42\" class=\"abstract_t\">40-42</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mental retardation and short stature [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/43\" class=\"abstract_t\">43</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anosmia, hypogonadotropic hypogonadism, nystagmus, and decreased visual acuity [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/44\" class=\"abstract_t\">44</a>]</p><p/><p class=\"headingAnchor\" id=\"H67481074\"><span class=\"h1\">PERINATAL MANIFESTATIONS OF STEROID SULFATASE DEFICIENCY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Steroid sulfatase (STS) is a key enzyme in the biosynthesis of estriol in the human placenta. A placental STS deficiency, which occurs in pregnancies of XLI fetuses, causes abnormally low levels of serum estriol in mothers during pregnancy. Recessive XLI may be diagnosed prenatally as an incidental finding in pregnant women undergoing a screening blood test for Down syndrome, which includes alpha-fetoprotein (AFP), unconjugated estriol, human chorionic gonadotropin, and inhibin A. (See <a href=\"topic.htm?path=down-syndrome-overview-of-prenatal-screening\" class=\"medical medical_review\">&quot;Down syndrome: Overview of prenatal screening&quot;</a>.)</p><p>The impact of STS deficiency on pregnancy and delivery is unclear. Some authors report a delayed labor (&gt;20 hours) and reduced response to <a href=\"topic.htm?path=oxytocin-drug-information\" class=\"drug drug_general\">oxytocin</a>, especially in primiparous women [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/23,45\" class=\"abstract_t\">23,45</a>]. However, no special interventions are recommended, unless there are specific obstetric indications [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/45,46\" class=\"abstract_t\">45,46</a>].</p><p class=\"headingAnchor\" id=\"H98140664\"><span class=\"h1\">DIAGNOSIS</span></p><p class=\"headingAnchor\" id=\"H59463696\"><span class=\"h2\">Clinical suspicion</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of recessive XLI is suspected in an infant based upon one or more of the following [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/1\" class=\"abstract_t\">1</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Presence of unusually dry skin in the first weeks of life that evolves to polygonal, brownish scales</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Birth history characterized by a prolonged (&gt;20 hours) labor <span class=\"nowrap\">and/or</span> nonelective cesarean section</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Maternal finding of low serum estriol in the second trimester of pregnancy</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Family history of scaly skin affecting the male relatives of the mother</p><p/><p>The diagnosis of recessive XLI can be confirmed by biochemical techniques demonstrating absent steroid sulfatase (STS) enzyme activity or by molecular techniques demonstrating a deletion or mutation of the <em>STS</em> gene.</p><p class=\"headingAnchor\" id=\"H98140670\"><span class=\"h2\">Biochemical diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The demonstration of reduced steroid sulfatase activity in cultured fibroblasts has the highest sensitivity because it detects cases caused by chromosomal deletions as well as those caused by mutations. Fibroblasts can be cultured from skin biopsy using a standard technique. Typically, a 4 mm punch biopsy from a convenient area of the skin (such as under the upper arm) is placed in a sterile container with standard culture media (<strong>not</strong> formalin) and sent to a laboratory that performs fibroblast culture. A request for STS enzyme activity testing should accompany the specimen.</p><p class=\"headingAnchor\" id=\"H98140676\"><span class=\"h2\">Molecular diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of recessive XLI can be confirmed by fluorescent in situ hybridization (FISH). Using FISH, the <em>STS</em> region of the X-chromosome (Xp22.3) can be examined for a microdeletion. FISH testing can be performed directly on blood, skin, or amniotic fluid. However, FISH cannot detect the minority of recessive XLI cases caused by point mutations in <em>STS</em>. (See <a href=\"topic.htm?path=tools-for-genetics-and-genomics-cytogenetics-and-molecular-genetics#H15538631\" class=\"medical medical_review\">&quot;Tools for genetics and genomics: Cytogenetics and molecular genetics&quot;, section on 'Fluorescence in situ hybridization'</a>.)</p><p>In suspected cases in which FISH is negative for an <em>STS</em> deletion, DNA sequencing for point mutations in <em>STS</em> can be performed. Information on laboratories performing genetic testing for the diagnosis of recessive XLI can be found on the website of the <a href=\"http://www.firstskinfoundation.org/content.cfm/Ichthyosis/Prenatal-Diagnosis-and-Testing-for-X-Linked-Ichthyosis/page_id/914&amp;token=XNC+JmoGg4Ajj08hd419SHOFePzDBIKNWxDRQVzmUkJsFHxcPaAGL/ohDOXh86QS93QrNXteuar2tIrn4aP9opR5Zv3kBsEoyKTxAJyQqaNwZGmgD1cVaKSuuaMC/X1PiKsTGlwYFKk0ChmRpz3qbw==&amp;TOPIC_ID=15472\" target=\"_blank\" class=\"external\">Foundation for Ichthyosis and Related Skin Types (FIRST)</a>.</p><p>Chromosomal microarray (CMA) is a powerful genetic test that interrogates the entire genome for small deletions and copy number variants. CMA is used in obstetrics for certain situations such as fetal congenital anomalies, and in the postnatal setting in children with multiple congenital anomalies not explained by a specific syndrome. (See <a href=\"topic.htm?path=use-of-chromosomal-microarray-in-obstetrics\" class=\"medical medical_review\">&quot;Use of chromosomal microarray in obstetrics&quot;</a>.)</p><p>CMA may detect recessive XLI prenatally and is also useful to exclude an associated contiguous gene syndrome. Similarly, in patients who present with suspected XLI and congenital anomalies, chromosomal microarray and genetic consultation may be helpful for accurate diagnosis.</p><p class=\"headingAnchor\" id=\"H59464413\"><span class=\"h2\">Prenatal diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Since the mothers of XLI-affected fetuses have abnormally low levels of serum estriol during pregnancy, the diagnosis is sometimes made prenatally in women who undergo a screening blood test for Down syndrome in the second trimester of pregnancy, which includes the measurement of unconjugated estriol. (See <a href=\"#H67481074\" class=\"local\">'Perinatal manifestations of steroid sulfatase deficiency'</a> above.)</p><p>When the diagnosis of <em>STS</em> deficiency is made prenatally, further evaluation to exclude a contiguous gene syndrome using chromosomal microarray is recommended [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/12\" class=\"abstract_t\">12</a>]. (See <a href=\"#H98140676\" class=\"local\">'Molecular diagnosis'</a> above.)</p><p class=\"headingAnchor\" id=\"H59464077\"><span class=\"h2\">Carrier detection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Fibroblast culture is not useful to detect carrier females. If an affected male is identified using chromosomal microarray (see <a href=\"#H98140676\" class=\"local\">'Molecular diagnosis'</a> above), DNA sequencing or FISH testing (see <a href=\"#H98140676\" class=\"local\">'Molecular diagnosis'</a> above), then female relatives such as the mother can be tested for carrier status using the same technique in a targeted fashion. Genetic consultation is useful for families to understand the testing strategy and implications of the findings.</p><p class=\"headingAnchor\" id=\"H98140688\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of XLI includes:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Ichthyosis vulgaris</strong> &ndash; In contrast to recessive XLI, the skin is likely to lack the translucent, polygonal scale of recessive XLI in infants and children with ichthyosis vulgaris. Palmar hyperlinearity is characteristic of ichthyosis vulgaris, but is usually absent in XLI (<a href=\"image.htm?imageKey=DERM%2F90481\" class=\"graphic graphic_picture graphicRef90481 \">picture 9</a>). On histology, the granular layer is absent in ichthyosis vulgaris but is usually normal or thinned in XLI. (See <a href=\"topic.htm?path=overview-and-classification-of-the-inherited-ichthyoses#H16647233\" class=\"medical medical_review\">&quot;Overview and classification of the inherited ichthyoses&quot;, section on 'Ichthyosis vulgaris'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Lamellar ichthyosis and congenital ichthyosiform erythroderma</strong> &ndash; Lamellar ichthyosis is more severe than XLI and typically presents at birth with a collodion membrane (<a href=\"image.htm?imageKey=DERM%2F62827\" class=\"graphic graphic_picture graphicRef62827 \">picture 10</a>). (See <a href=\"topic.htm?path=overview-and-classification-of-the-inherited-ichthyoses#H62154308\" class=\"medical medical_review\">&quot;Overview and classification of the inherited ichthyoses&quot;, section on 'Lamellar ichthyosis and congenital ichthyosiform erythroderma'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Atopic dermatitis</strong> &ndash; In infants and young children, atopic dermatitis typically presents with dry skin, pruritus, and red, scaly, or weeping lesions on the extensor surfaces and cheeks or scalp (<a href=\"image.htm?imageKey=ALLRG%2F77457%7EALLRG%2F56461%7EDERM%2F77386\" class=\"graphic graphic_picture graphicRef77457 graphicRef56461 graphicRef77386 \">picture 11A-C</a>). Histology shows spongiosis (epidermal edema) and a lymphohistiocytic infiltrate in the dermis. In contrast to atopic dermatitis, XLI is not associated with inflammation, vesiculation, or pruritus. However, atopic dermatitis may rarely be present concurrently with XLI. Individuals with recessive XLI have heightened risk of atopic dermatitis, and the two conditions may occur together. (See <a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H98140694\"><span class=\"h1\">MANAGEMENT</span></p><p class=\"headingAnchor\" id=\"H58479426\"><span class=\"h2\">General considerations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is no definitive cure for recessive XLI. The disease rarely interferes with the activities of daily living and individuals with mild forms may not require treatment [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/1\" class=\"abstract_t\">1</a>]. However, some patients with XLI experience a significantly reduced quality of life, due to self-consciousness and social embarrassment [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/47-49\" class=\"abstract_t\">47-49</a>]. These patients may need lifelong treatment to control scaling and skin dryness and improve their skin appearance.</p><p>Education of parents and patients about the importance of daily bathing and regular, frequent application of emollients is an essential part of the management of XLI. It is also essential to guide the patient in the choice of cosmetically acceptable creams and lotions to improve <span class=\"nowrap\">his/her</span> compliance to treatment [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/50\" class=\"abstract_t\">50</a>]. An excellent resource for patients and parents with information on skin care can be found on the website of the <a href=\"http://www.firstskinfoundation.org/&amp;token=d6NQlKznXXsPNyyDrHcWUm8LQ3ZZ86pWRcayvUXs1x0UHtm6yxkstuoc4WcJ/0I0&amp;TOPIC_ID=15472\" target=\"_blank\" class=\"external\">Foundation for Ichthyosis and Related Skin Types (FIRST)</a>.</p><p class=\"headingAnchor\" id=\"H403536567\"><span class=\"h2\">Overheating</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In some individuals, the skin is dry and thick enough to impede normal function of the sweat glands by mechanically blocking them. These patients may have a tendency to become overheated, especially in direct sunlight [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/1\" class=\"abstract_t\">1</a>]. One of the first signs of overheating is increased redness of the skin. Ready access to a cool environment or water, if needed, is recommended.</p><p>Affected individuals usually learn over time what they can or cannot tolerate, and overheating rarely causes medical problems.</p><p class=\"headingAnchor\" id=\"H98140700\"><span class=\"h2\">Control of scaling and dryness</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Treatment of recessive XLI is directed at removing scales, reducing skin dryness, and improving skin appearance without causing excessive irritation. It involves regular bathing and use of emollients and keratolytics. Patients with severe disease may benefit from intermittent use of topical or systemic retinoids.</p><p>Daily bathtub soaks in water or long showers with gentle removal of scale using a roughly textured sponge are helpful. Addition of baking soda or lubricating bath oils to bath water may be helpful [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/51\" class=\"abstract_t\">51</a>]. Moisturizing creams or ointments should be applied immediately after bathing, while the skin is still damp. Useful moisturizers typically contain oils alone (eg, petroleum jelly) or in combination with humectants (eg, <a href=\"topic.htm?path=sodium-lactate-drug-information\" class=\"drug drug_general\">sodium lactate</a>, low-concentration urea, propylene glycol).</p><p class=\"headingAnchor\" id=\"H58479475\"><span class=\"h3\">Infants and young children</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In neonates with XLI, maintaining skin hydration with environmental humidity and bland emollients is usually sufficient to remove the thin scales and prevent their formation. In infants and young children, daily baths followed by the application of emollients is usually sufficient to remove scales. The application of topical keratolytics should be avoided because of the high risk of toxicity due to systemic absorption [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/52-54\" class=\"abstract_t\">52-54</a>].</p><p class=\"headingAnchor\" id=\"H58479481\"><span class=\"h3\">Older children and adults</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with thick scales and markedly increased stratum corneum thickness benefit from creams or ointments containing one or more keratolytic agents such as alpha-hydroxyacids (lactic acid and glycolic acid), salicylic acid, urea at high concentration, and propylene glycol.</p><p>Keratolytic preparations available on the market usually contain 5 to 12% lactic acid, 2 to 10% urea, 5 to 15% glycolic acid, 10 to 25% propylene glycol, or 3 to 6% salicylic acid. An excessive concentration of keratolytic agents may cause skin irritation, pain, and excess peeling. As a general rule, concentration of keratolytic creams may be increased in a &quot;start low, go slow,&quot; stepwise fashion to avoid burning and irritation. Patients with unsatisfactory response to single keratolytics may benefit from using ointments containing a combination of keratolytics, such as 5% lactic acid with 10% urea or 2% salicylic acid with 20% urea.</p><p>Evidence on the efficacy of keratolytics for the treatment of ichthyosis is limited to a few low-quality randomized trials and observational studies, and their use is mainly based upon clinical experience and patient preference. In one study, 60 children with mild to moderate types of ichthyosis treated one side of the most severely affected extremity with a 10% urea cream and the contralateral side with vehicle for eight weeks [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/55\" class=\"abstract_t\">55</a>]. A very good or good investigator-assessed improvement was noted in more areas treated with 10% urea lotion than those treated with vehicle (79 versus 62 percent).</p><p class=\"headingAnchor\" id=\"H59464440\"><span class=\"h3\">Patients with severe XLI</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Adult patients with more severe forms of XLI may benefit of intermittent courses of topical retinoids (eg, <a href=\"topic.htm?path=tazarotene-drug-information\" class=\"drug drug_general\">tazarotene</a>) or oral retinoids (eg, <a href=\"topic.htm?path=isotretinoin-drug-information\" class=\"drug drug_general\">isotretinoin</a>, <a href=\"topic.htm?path=acitretin-drug-information\" class=\"drug drug_general\">acitretin</a>). Retinoids have anti-keratinizing properties and modulate keratinocyte proliferation and differentiation. An alternative to topical or systemic retinoids are retinoic acid metabolism-blocking agents such as liarozole and rambazole. Liarozole has received the orphan drug status by the United States Federal Drug Administration and the European Medicines Agency for the treatment of congenital ichthyosis, but it is not yet available on the market.</p><p>Evidence on the efficacy of topical or systemic retinoids in XLI is limited to a few small uncontrolled studies and single-case reports and one randomized trial [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/56-59\" class=\"abstract_t\">56-59</a>]. However, their use is supported by evidence of efficacy in other types of severe congenital ichthyoses and by clinical experience.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In one right-left comparison study, 12 patients with congenital ichthyosis (4 with XLI) applied <a href=\"topic.htm?path=tazarotene-drug-information\" class=\"drug drug_general\">tazarotene</a> 0.05% gel on a skin area &le;10 percent of the body surface area and an ointment containing 10% urea on the contralateral area twice daily for two weeks and then twice weekly for two additional weeks [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/56\" class=\"abstract_t\">56</a>]. In the four patients with recessive XLI, a marked clinical improvement was noted only on the side treated with tazarotene after 14 to 20 days, and the beneficial effect persisted for up to two months after discontinuing tazarotene. Adverse effects of tazarotene were mild irritation and discomfort that did not require the interruption of treatment.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a small right-left comparison trial, liarozole 5% cream was more effective than vehicle in reducing scaling and roughness in 12 patients with recessive XLI, epidermolytic ichthyosis, or lamellar ichthyosis [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/58\" class=\"abstract_t\">58</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a randomized trial including 32 patients (21 with XLI), oral liarozole 150 mg per day was as effective as oral <a href=\"topic.htm?path=acitretin-drug-information\" class=\"drug drug_general\">acitretin</a> 35 mg per day in inducing a marked improvement in scaling and erythema, as assessed by clinician evaluation and patient self-evaluation [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/59\" class=\"abstract_t\">59</a>]. Adverse events were moderate and less frequent in the liarozole group.</p><p/><p>The use of topical retinoids is limited because of concern for systemic absorption due to application on large body areas for long periods of time. However, the transepidermal absorption of <a href=\"topic.htm?path=tazarotene-drug-information\" class=\"drug drug_general\">tazarotene</a> appears to be negligible. In a small study including nine children with ichthyosis (four with XLI), patients applied 0.05% or 0.1% tazarotene cream or gel on 20 to 90 percent of the body area for one month to two years [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/60\" class=\"abstract_t\">60</a>]. The blood levels of tazarotene were measured 12 to 25 hours after the last application. Of nine patients, seven had undetectable levels of tazarotene or tazarotenic acid, and two had levels &lt;0.3 <span class=\"nowrap\">ng/mL</span>.</p><p>Adverse effects of systemic retinoids include mucosal dryness, photosensitivity, hyperlipidemia, transaminase elevation, and skeletal hyperostosis. Because recessive XLI only affects males, the risk of teratogenicity associated with systemic retinoids is not a concern.</p><p class=\"headingAnchor\" id=\"H98140712\"><span class=\"h2\">Management of extracutaneous manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with extracutaneous manifestations and patients with contiguous gene syndromes may require a specialized or multidisciplinary approach.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The corneal punctate opacities in X-linked ichthyosis are asymptomatic and generally do not cause harm. A baseline ophthalmology exam using a slit lamp to examine the cornea can be considered at baseline to document the presence or absence of corneal changes associated with XLI.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The management of cryptorchidism is discussed elsewhere (see <a href=\"topic.htm?path=undescended-testes-cryptorchidism-in-children-clinical-features-and-evaluation\" class=\"medical medical_review\">&quot;Undescended testes (cryptorchidism) in children: Clinical features and evaluation&quot;</a>). Of particular concern to patients and families is a possible association of XLI with testicular germ cell cancer [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/30,61\" class=\"abstract_t\">30,61</a>]. The data to support a true connection are weak [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/14\" class=\"abstract_t\">14</a>]. Because the evidence for a true association of XLI with testicular cancer is weak outside the setting of cryptorchidism, no additional screening measures are recommended for patients without a history of cryptorchidism. (See <a href=\"topic.htm?path=epidemiology-of-and-risk-factors-for-testicular-germ-cell-tumors\" class=\"medical medical_review\">&quot;Epidemiology of and risk factors for testicular germ cell tumors&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The management of children with contiguous gene syndromes who present with developmental, endocrine, or neurologic abnormalities <span class=\"nowrap\">and/or</span> intellectual disability requires a multidisciplinary team, including a pediatrician, a pediatric neurologist, a geneticist, and occupational and physical therapists.</p><p/><p class=\"headingAnchor\" id=\"H98140742\"><span class=\"h2\">Genetic counseling</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients diagnosed with recessive XLI may benefit from genetics consultation to better understand the inheritance pattern and impact on family members. Mothers who are carriers of steroid sulfatase deficiency will pass the X-chromosome bearing the <em>STS</em> deletion or mutation to 50 percent of offspring. Therefore, 50 percent of sons will be affected by recessive XLI and 50 percent of daughters will be carriers (<a href=\"image.htm?imageKey=PC%2F55180\" class=\"graphic graphic_figure graphicRef55180 \">figure 1</a>). Affected fathers will never transmit the disease to their sons, but all daughters will be carriers. (See <a href=\"topic.htm?path=inheritance-patterns-of-monogenic-disorders-mendelian-and-non-mendelian#H11\" class=\"medical medical_review\">&quot;Inheritance patterns of monogenic disorders (Mendelian and non-Mendelian)&quot;, section on 'Sex-linked'</a>.)</p><p class=\"headingAnchor\" id=\"H98140748\"><span class=\"h1\">PROGNOSIS AND FOLLOW-UP</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the absence of a contiguous gene syndrome,<strong> </strong>the prognosis for patients affected with recessive XLI is excellent. There is no known reduction in life expectancy associated with XLI [<a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/1\" class=\"abstract_t\">1</a>]. For patients with severe skin dryness and scaling, scheduled dermatologic follow-up (eg, every six weeks) is recommended until the skin dryness is improved and well managed by the patient <span class=\"nowrap\">and/or</span> family. In milder cases, &quot;as needed&quot; periodic follow-up is usually sufficient.</p><p class=\"headingAnchor\" id=\"H98140760\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Recessive X-linked ichthyosis (XLI, MIM #308100), also called steroid sulfatase deficiency, is an X-linked recessive, nonsyndromic ichthyosis caused by deletions or mutations in the <em>STS</em> gene encoding the steroid sulfatase (STS) enzyme. (See <a href=\"#H98140592\" class=\"local\">'Introduction'</a> above and <a href=\"#H98140604\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The cutaneous features of recessive XLI may appear in the first few weeks of life with mild, diffuse scaling (<a href=\"image.htm?imageKey=DERM%2F103928%7EDERM%2F103927%7EDERM%2F103929%7EDERM%2F103930\" class=\"graphic graphic_picture graphicRef103928 graphicRef103927 graphicRef103929 graphicRef103930 \">picture 4A-D</a>) and develop gradually over the following months. Over time, the mild desquamation may be replaced by large polygonal, brownish scales that involve particularly the anterior aspect of the lower extremities (<a href=\"image.htm?imageKey=PEDS%2F66723%7EDERM%2F90658\" class=\"graphic graphic_picture graphicRef66723 graphicRef90658 \">picture 5A-B</a>). The flexural areas tend to be spared. (See <a href=\"#H98140622\" class=\"local\">'Cutaneous features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Extracutaneous features include asymptomatic punctate corneal opacities and cryptorchidism. Deletions of the <em>STS</em> genes and adjacent genes result in complicated clinical phenotypes called contiguous gene syndromes. (See <a href=\"#H59463924\" class=\"local\">'Extracutaneous features'</a> above and <a href=\"#H98140652\" class=\"local\">'Contiguous gene syndromes'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of recessive XLI can be confirmed by biochemical techniques demonstrating absent STS enzyme activity in cultured fibroblasts or by molecular techniques demonstrating a deletion or point mutation of the <em>STS</em> gene. Chromosomal microarray (CMA) may be used to exclude an associated contiguous gene syndrome. (See <a href=\"#H98140664\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There is no definitive cure for recessive XLI. Treatment is directed at removing scales, reducing skin dryness, and improving skin appearance without causing excessive irritation. It involves regular bathing and use of emollients and keratolytics. Patients with severe disease may benefit from intermittent use of topical or systemic retinoids. (See <a href=\"#H98140694\" class=\"local\">'Management'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/1\" class=\"nounderline abstract_t\">Fernandes NF, Janniger CK, Schwartz RA. X-linked ichthyosis: an oculocutaneous genodermatosis. J Am Acad Dermatol 2010; 62:480.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/2\" class=\"nounderline abstract_t\">Craig WY, Roberson M, Palomaki GE, et al. Prevalence of steroid sulfatase deficiency in California according to race and ethnicity. Prenat Diagn 2010; 30:893.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/3\" class=\"nounderline abstract_t\">Sakura N, Nishimura SI, Matsumoto T, Ohsaki M. Frequency of steroid sulfatase deficiency in Hiroshima. Acta Paediatr Jpn 1998; 40:63.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/4\" class=\"nounderline abstract_t\">David M, Israel N, Merksamer R, et al. Very low maternal serum unconjugated estriol and prenatal diagnosis of steroid sulfatase deficiency. Fetal Diagn Ther 1995; 10:76.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/5\" class=\"nounderline abstract_t\">Ingordo V, D'Andria G, Gentile C, et al. Frequency of X-linked ichthyosis in coastal southern Italy: a study on a representative sample of a young male population. Dermatology 2003; 207:148.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/6\" class=\"nounderline abstract_t\">Ca&ntilde;ueto J, Ciria S, Hern&aacute;ndez-Mart&iacute;n A, et al. Analysis of the STS gene in 40 patients with recessive X-linked ichthyosis: a high frequency of partial deletions in a Spanish population. J Eur Acad Dermatol Venereol 2010; 24:1226.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/7\" class=\"nounderline abstract_t\">Ballabio A, Carrozzo R, Parenti G, et al. Molecular heterogeneity of steroid sulfatase deficiency: a multicenter study on 57 unrelated patients, at DNA and protein levels. Genomics 1989; 4:36.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/8\" class=\"nounderline abstract_t\">Oyama N, Matsuda M, Hamada T, et al. Two novel missense mutations of STS gene underlie X-linked recessive ichthyosis: understanding of the mutational and structural spectrum. J Eur Acad Dermatol Venereol 2016; 30:1629.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/9\" class=\"nounderline abstract_t\">Alperin ES, Shapiro LJ. Characterization of point mutations in patients with X-linked ichthyosis. Effects on the structure and function of the steroid sulfatase protein. J Biol Chem 1997; 272:20756.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/10\" class=\"nounderline abstract_t\">Valdes-Flores M, Kofman-Alfaro SH, Jimenez-Vaca AL, Cuevas-Covarrubias SA. Carrier identification by FISH analysis in isolated cases of X-linked ichthyosis. Am J Med Genet 2001; 102:146.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/11\" class=\"nounderline abstract_t\">Cuevas-Covarrubias SA, Valdes-Flores M, Orozco Orozco E, et al. Most &quot;sporadic&quot; cases of X-linked ichthyosis are not de novo mutations. Acta Derm Venereol 1999; 79:143.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/12\" class=\"nounderline abstract_t\">Langlois S, Armstrong L, Gall K, et al. Steroid sulfatase deficiency and contiguous gene deletion syndrome amongst pregnant patients with low serum unconjugated estriols. Prenat Diagn 2009; 29:966.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/13\" class=\"nounderline abstract_t\">Chocholska S, Rossier E, Barbi G, Kehrer-Sawatzki H. Molecular cytogenetic analysis of a familial interstitial deletion Xp22.2-22.3 with a highly variable phenotype in female carriers. Am J Med Genet A 2006; 140:604.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/14\" class=\"nounderline abstract_t\">Elias PM, Williams ML, Choi EH, Feingold KR. Role of cholesterol sulfate in epidermal structure and function: lessons from X-linked ichthyosis. Biochim Biophys Acta 2014; 1841:353.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/15\" class=\"nounderline abstract_t\">Reed MJ, Purohit A, Woo LW, et al. Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr Rev 2005; 26:171.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/16\" class=\"nounderline abstract_t\">Elias PM, Williams ML, Maloney ME, et al. Stratum corneum lipids in disorders of cornification. Steroid sulfatase and cholesterol sulfate in normal desquamation and the pathogenesis of recessive X-linked ichthyosis. J Clin Invest 1984; 74:1414.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/17\" class=\"nounderline abstract_t\">Sato J, Denda M, Nakanishi J, et al. Cholesterol sulfate inhibits proteases that are involved in desquamation of stratum corneum. J Invest Dermatol 1998; 111:189.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/18\" class=\"nounderline abstract_t\">Zettersten E, Man MQ, Sato J, et al. Recessive x-linked ichthyosis: role of cholesterol-sulfate accumulation in the barrier abnormality. J Invest Dermatol 1998; 111:784.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/19\" class=\"nounderline abstract_t\">Hand JL, Runke CK, Hodge JC. The phenotype spectrum of X-linked ichthyosis identified by chromosomal microarray. J Am Acad Dermatol 2015; 72:617.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/20\" class=\"nounderline abstract_t\">Yang CS, Pomerantz H, Mannava KA, et al. Comparing histopathology from patients with X-linked recessive ichthyosis and autosomal recessive congenital ichthyosis with transglutaminase 1 mutation: A report from the National Registry for Ichthyosis and Related Skin Disorders. J Am Acad Dermatol 2016; 74:1008.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/21\" class=\"nounderline abstract_t\">Kent L, Emerton J, Bhadravathi V, et al. X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits. J Med Genet 2008; 45:519.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/22\" class=\"nounderline abstract_t\">Brookes KJ, Hawi Z, Kirley A, et al. Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:1531.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/23\" class=\"nounderline abstract_t\">Bradley LA, Canick JA, Palomaki GE, Haddow JE. Undetectable maternal serum unconjugated estriol levels in the second trimester: risk of perinatal complications associated with placental sulfatase deficiency. Am J Obstet Gynecol 1997; 176:531.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/24\" class=\"nounderline abstract_t\">Hern&aacute;ndez-Mart&iacute;n A, Gonz&aacute;lez-Sarmiento R, De Unamuno P. X-linked ichthyosis: an update. Br J Dermatol 1999; 141:617.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/25\" class=\"nounderline abstract_t\">Ramesh R, Chen H, Kukula A, et al. Exacerbation of X-linked ichthyosis phenotype in a female by inheritance of filaggrin and steroid sulfatase mutations. J Dermatol Sci 2011; 64:159.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/26\" class=\"nounderline abstract_t\">Liao H, Waters AJ, Goudie DR, et al. Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis. J Invest Dermatol 2007; 127:2795.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/27\" class=\"nounderline abstract_t\">Cuevas-Covarrubias SA, Valdes-Flores M, Rivera-Vega MR, et al. Ichthyosis vulgaris and X-linked ichthyosis: simultaneous segregation in the same family. Acta Derm Venereol 1999; 79:494.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/28\" class=\"nounderline abstract_t\">Hung C, Ayabe RI, Wang C, et al. Pre-Descemet corneal dystrophy and X-linked ichthyosis associated with deletion of Xp22.31 containing the STS gene. Cornea 2013; 32:1283.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/29\" class=\"nounderline abstract_t\">Shi H, Qi XF, Liu TT, et al. In vivo confocal microscopy of pre-Descemet corneal dystrophy associated with X-linked ichthyosis: a case report. BMC Ophthalmol 2017; 17:29.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/30\" class=\"nounderline abstract_t\">Lykkesfeldt G, Bennett P, Lykkesfeldt AE, et al. Testis cancer. Ichthyosis constitutes a significant risk factor. Cancer 1991; 67:730.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/31\" class=\"nounderline abstract_t\">Lykkesfeldt G, H&oslash;yer H, Lykkesfeldt AE, Skakkebaek NE. Steroid sulphatase deficiency associated with testis cancer. Lancet 1983; 2:1456.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/32\" class=\"nounderline abstract_t\">Mishra K, Batra VV, Basu S, et al. Steroid-resistant nephrotic syndrome associated with steroid sulfatase deficiency-x-linked recessive ichthyosis: a case report and review of literature. Eur J Pediatr 2012; 171:847.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/33\" class=\"nounderline abstract_t\">Krishnamurthy S, Kapoor S, Yadav S. Nephrotic syndrome with X-linked ichthyosis, Kallmann Syndrome and unilateral renal agenesis. Indian Pediatr 2007; 44:301.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/34\" class=\"nounderline abstract_t\">Matsukura H, Fuchizawa T, Ohtsuki A, et al. End-stage renal failure in a child with X-linked ichthyosis. Pediatr Nephrol 2003; 18:297.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/35\" class=\"nounderline abstract_t\">Song Y, Chen J, Yi Z, et al. Genetic analysis of a 12-year-old boy with X-linked ichthyosis in association with sclerosing glomerulonephritis. Mol Med Rep 2013; 8:1183.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/36\" class=\"nounderline abstract_t\">Ballabio A, Bardoni B, Carrozzo R, et al. Contiguous gene syndromes due to deletions in the distal short arm of the human X chromosome. Proc Natl Acad Sci U S A 1989; 86:10001.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/37\" class=\"nounderline abstract_t\">Van Esch H, Hollanders K, Badisco L, et al. Deletion of VCX-A due to NAHR plays a major role in the occurrence of mental retardation in patients with X-linked ichthyosis. Hum Mol Genet 2005; 14:1795.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/38\" class=\"nounderline abstract_t\">Ozawa H, Osawa M, Nagai T, Sakura N. Steroid sulfatase deficiency with bilateral periventricular nodular heterotopia. Pediatr Neurol 2006; 34:239.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/39\" class=\"nounderline abstract_t\">Ballabio A, Parenti G, Tippett P, et al. X-linked ichthyosis, due to steroid sulphatase deficiency, associated with Kallmann syndrome (hypogonadotropic hypogonadism and anosmia): linkage relationships with Xg and cloned DNA sequences from the distal short arm of the X chromosome. Hum Genet 1986; 72:237.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/40\" class=\"nounderline abstract_t\">Curry CJ, Magenis RE, Brown M, et al. Inherited chondrodysplasia punctata due to a deletion of the terminal short arm of an X chromosome. N Engl J Med 1984; 311:1010.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/41\" class=\"nounderline abstract_t\">Bick DP, Schorderet DF, Price PA, et al. Prenatal diagnosis and investigation of a fetus with chondrodysplasia punctata, ichthyosis, and Kallmann syndrome due to an Xp deletion. Prenat Diagn 1992; 12:19.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/42\" class=\"nounderline abstract_t\">Ballabio A, Parenti G, Carrozzo R, et al. X/Y translocation in a family with X-linked ichthyosis, chondrodysplasia punctata, and mental retardation: DNA analysis reveals deletion of the steroid sulphatase gene and translocation of its Y pseudogene. Clin Genet 1988; 34:31.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/43\" class=\"nounderline abstract_t\">Ross JB, Allderdice PW, Shapiro LJ, et al. Familial X-linked ichthyosis, steroid sulfatase deficiency, mental retardation, and nullisomy for Xp223-pter. Arch Dermatol 1985; 121:1524.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/44\" class=\"nounderline abstract_t\">Sunohara N, Sakuragawa N, Satoyoshi E, et al. A new syndrome of anosmia, ichthyosis, hypogonadism, and various neurological manifestations with deficiency of steroid sulfatase and arylsulfatase C. Ann Neurol 1986; 19:174.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/45\" class=\"nounderline abstract_t\">Jari SD, Fraer LM, Hogge WA. Association of undetectable unconjugated estriol on multiple marker screening with steroid sulfatase deficiency. Fetal Diagn Ther 2004; 19:43.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/46\" class=\"nounderline abstract_t\">Bedin M, Fournier T, Cabrol D, et al. Incidence of placental sulfatase deficiency on the mode of termination of pregnancy. Gynecol Obstet Invest 1987; 24:86.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/47\" class=\"nounderline abstract_t\">G&aring;nemo A, Sj&ouml;den PO, Johansson E, et al. Health-related quality of life among patients with ichthyosis. Eur J Dermatol 2004; 14:61.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/48\" class=\"nounderline abstract_t\">Dreyfus I, Pauwels C, Bourrat E, et al. Burden of inherited ichthyosis: a French national survey. Acta Derm Venereol 2015; 95:326.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/49\" class=\"nounderline abstract_t\">G&aring;nemo A. Quality of life in Swedish children with congenital ichthyosis. Dermatol Reports 2010; 2:e7.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/50\" class=\"nounderline abstract_t\">Vahlquist A, G&aring;nemo A, Virtanen M. Congenital ichthyosis: an overview of current and emerging therapies. Acta Derm Venereol 2008; 88:4.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/51\" class=\"nounderline abstract_t\">Milstone LM. Scaly skin and bath pH: rediscovering baking soda. J Am Acad Dermatol 2010; 62:885.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/52\" class=\"nounderline abstract_t\">Ram&iacute;rez ME, Youseef WF, Romero RG, et al. Acute percutaneous lactic acid poisoning in a child. Pediatr Dermatol 2006; 23:282.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/53\" class=\"nounderline abstract_t\">Brubacher JR, Hoffman RS. Salicylism from topical salicylates: review of the literature. J Toxicol Clin Toxicol 1996; 34:431.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/54\" class=\"nounderline abstract_t\">Chiaretti A, Schembri Wismayer D, Tortorolo L, et al. Salicylate intoxication using a skin ointment. Acta Paediatr 1997; 86:330.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/55\" class=\"nounderline abstract_t\">K&uuml;ster W, Bohnsack K, Rippke F, et al. Efficacy of urea therapy in children with ichthyosis. A multicenter randomized, placebo-controlled, double-blind, semilateral study. Dermatology 1998; 196:217.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/56\" class=\"nounderline abstract_t\">Hofmann B, Stege H, Ruzicka T, Lehmann P. Effect of topical tazarotene in the treatment of congenital ichthyoses. Br J Dermatol 1999; 141:642.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/57\" class=\"nounderline abstract_t\">Cotellessa C, Cuevas-Covarrubias SA, Valeri P, et al. Topical tazarotene 0.05% versus glycolic acid 70% treatment in X-linked ichthyosis due to extensive deletion of the STS gene. Acta Derm Venereol 2005; 85:346.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/58\" class=\"nounderline abstract_t\">Lucker GP, Verfaille CJ, Heremans AM, et al. Topical liarozole in ichthyosis: a double-blind, left-right comparative study followed by a long-term open maintenance study. Br J Dermatol 2005; 152:566.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/59\" class=\"nounderline abstract_t\">Verfaille CJ, Vanhoutte FP, Blanchet-Bardon C, et al. Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study. Br J Dermatol 2007; 156:965.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/60\" class=\"nounderline abstract_t\">Nguyen V, Cunningham BB, Eichenfield LF, et al. Treatment of ichthyosiform diseases with topically applied tazarotene: risk of systemic absorption. J Am Acad Dermatol 2007; 57:S123.</a></li><li><a href=\"https://www.uptodate.com/contents/recessive-x-linked-ichthyosis/abstract/61\" class=\"nounderline abstract_t\">Lykkesfeldt G, H&oslash;yer H. Topical cholesterol treatment of recessive X-linked ichthyosis. Lancet 1983; 2:1337.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 15472 Version 10.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H98140760\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H98140592\" id=\"outline-link-H98140592\">INTRODUCTION</a></li><li><a href=\"#H98140598\" id=\"outline-link-H98140598\">EPIDEMIOLOGY</a></li><li><a href=\"#H98140604\" id=\"outline-link-H98140604\">PATHOGENESIS</a></li><li><a href=\"#H55326\" id=\"outline-link-H55326\">PATHOLOGY</a></li><li><a href=\"#H98140610\" id=\"outline-link-H98140610\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H98140622\" id=\"outline-link-H98140622\">Cutaneous features</a></li><li><a href=\"#H59463924\" id=\"outline-link-H59463924\">Extracutaneous features</a><ul><li><a href=\"#H98140628\" id=\"outline-link-H98140628\">- Ocular</a></li><li><a href=\"#H98140634\" id=\"outline-link-H98140634\">- Genitourinary</a></li><li><a href=\"#H98140646\" id=\"outline-link-H98140646\">- Cognitive and behavioral</a></li></ul></li><li><a href=\"#H98140652\" id=\"outline-link-H98140652\">Contiguous gene syndromes</a></li></ul></li><li><a href=\"#H67481074\" id=\"outline-link-H67481074\">PERINATAL MANIFESTATIONS OF STEROID SULFATASE DEFICIENCY</a></li><li><a href=\"#H98140664\" id=\"outline-link-H98140664\">DIAGNOSIS</a><ul><li><a href=\"#H59463696\" id=\"outline-link-H59463696\">Clinical suspicion</a></li><li><a href=\"#H98140670\" id=\"outline-link-H98140670\">Biochemical diagnosis</a></li><li><a href=\"#H98140676\" id=\"outline-link-H98140676\">Molecular diagnosis</a></li><li><a href=\"#H59464413\" id=\"outline-link-H59464413\">Prenatal diagnosis</a></li><li><a href=\"#H59464077\" id=\"outline-link-H59464077\">Carrier detection</a></li></ul></li><li><a href=\"#H98140688\" id=\"outline-link-H98140688\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H98140694\" id=\"outline-link-H98140694\">MANAGEMENT</a><ul><li><a href=\"#H58479426\" id=\"outline-link-H58479426\">General considerations</a></li><li><a href=\"#H403536567\" id=\"outline-link-H403536567\">Overheating</a></li><li><a href=\"#H98140700\" id=\"outline-link-H98140700\">Control of scaling and dryness</a><ul><li><a href=\"#H58479475\" id=\"outline-link-H58479475\">- Infants and young children</a></li><li><a href=\"#H58479481\" id=\"outline-link-H58479481\">- Older children and adults</a></li><li><a href=\"#H59464440\" id=\"outline-link-H59464440\">- Patients with severe XLI</a></li></ul></li><li><a href=\"#H98140712\" id=\"outline-link-H98140712\">Management of extracutaneous manifestations</a></li><li><a href=\"#H98140742\" id=\"outline-link-H98140742\">Genetic counseling</a></li></ul></li><li><a href=\"#H98140748\" id=\"outline-link-H98140748\">PROGNOSIS AND FOLLOW-UP</a></li><li><a href=\"#H98140760\" id=\"outline-link-H98140760\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/15472|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=PC/55180\" class=\"graphic graphic_figure\">- X-linked recessive--pedigree</a></li></ul></li><li><div id=\"DERM/15472|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/104127\" class=\"graphic graphic_picture\">- X-linked ichthyosis histo 1</a></li><li><a href=\"image.htm?imageKey=DERM/104128\" class=\"graphic graphic_picture\">- X-linked ichthyosis histo 2</a></li><li><a href=\"image.htm?imageKey=DERM/104129\" class=\"graphic graphic_picture\">- X-linked ichthyosis histo 3</a></li><li><a href=\"image.htm?imageKey=DERM/103928\" class=\"graphic graphic_picture\">- X-linked ichthyosis abdomen</a></li><li><a href=\"image.htm?imageKey=DERM/103927\" class=\"graphic graphic_picture\">- X-linked ichthyosis back</a></li><li><a href=\"image.htm?imageKey=DERM/103929\" class=\"graphic graphic_picture\">- X-linked ichthyosis shoulder</a></li><li><a href=\"image.htm?imageKey=DERM/103930\" class=\"graphic graphic_picture\">- X-linked ichthyosis leg</a></li><li><a href=\"image.htm?imageKey=PEDS/66723\" class=\"graphic graphic_picture\">- X-linked ichthyosis</a></li><li><a href=\"image.htm?imageKey=DERM/90658\" class=\"graphic graphic_picture\">- X-linked ichthyosis 2</a></li><li><a href=\"image.htm?imageKey=DERM/103931\" class=\"graphic graphic_picture\">- X-linked ichthyosis popliteal sparing</a></li><li><a href=\"image.htm?imageKey=DERM/103932\" class=\"graphic graphic_picture\">- X-linked ichthyosis antecubital sparing</a></li><li><a href=\"image.htm?imageKey=DERM/103934\" class=\"graphic graphic_picture\">- X-linked ichthyosis cornea</a></li><li><a href=\"image.htm?imageKey=DERM/90481\" class=\"graphic graphic_picture\">- Ichthyosis vulgaris palmar hyperlinearity</a></li><li><a href=\"image.htm?imageKey=DERM/62827\" class=\"graphic graphic_picture\">- Collodion baby</a></li><li><a href=\"image.htm?imageKey=ALLRG/77457\" class=\"graphic graphic_picture\">- Infantile atopic dermatitis widespread</a></li><li><a href=\"image.htm?imageKey=ALLRG/56461\" class=\"graphic graphic_picture\">- Atopic dermatitis infantile II</a></li><li><a href=\"image.htm?imageKey=DERM/77386\" class=\"graphic graphic_picture\">- Atopic dermatitis infant 2</a></li></ul></li><li><div id=\"DERM/15472|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/90504\" class=\"graphic graphic_table\">- Inherited ichthyoses nonsyndromic</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=attention-deficit-hyperactivity-disorder-in-children-and-adolescents-epidemiology-and-pathogenesis\" class=\"medical medical_review\">Attention deficit hyperactivity disorder in children and adolescents: Epidemiology and pathogenesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=autism-spectrum-disorder-terminology-epidemiology-and-pathogenesis\" class=\"medical medical_review\">Autism spectrum disorder: Terminology, epidemiology, and pathogenesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=down-syndrome-overview-of-prenatal-screening\" class=\"medical medical_review\">Down syndrome: Overview of prenatal screening</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-of-and-risk-factors-for-testicular-germ-cell-tumors\" class=\"medical medical_review\">Epidemiology of and risk factors for testicular germ cell tumors</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=inheritance-patterns-of-monogenic-disorders-mendelian-and-non-mendelian\" class=\"medical medical_review\">Inheritance patterns of monogenic disorders (Mendelian and non-Mendelian)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=isolated-gonadotropin-releasing-hormone-deficiency-idiopathic-hypogonadotropic-hypogonadism\" class=\"medical medical_review\">Isolated gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=laboratory-issues-related-to-maternal-serum-screening-for-down-syndrome\" class=\"medical medical_review\">Laboratory issues related to maternal serum screening for Down syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-and-classification-of-the-inherited-ichthyoses\" class=\"medical medical_review\">Overview and classification of the inherited ichthyoses</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tools-for-genetics-and-genomics-cytogenetics-and-molecular-genetics\" class=\"medical medical_review\">Tools for genetics and genomics: Cytogenetics and molecular genetics</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=undescended-testes-cryptorchidism-in-children-clinical-features-and-evaluation\" class=\"medical medical_review\">Undescended testes (cryptorchidism) in children: Clinical features and evaluation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=undescended-testes-cryptorchidism-in-children-management\" class=\"medical medical_review\">Undescended testes (cryptorchidism) in children: Management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=use-of-chromosomal-microarray-in-obstetrics\" class=\"medical medical_review\">Use of chromosomal microarray in obstetrics</a></li></ul></div></div>","javascript":null}